CoreWeave all-stock acquisition of Core Scientific
Company: Core Scientific
The claim, verbatim
On July 7, 2025 Core Scientific entered into a merger agreement under which CoreWeave will acquire the company in an all-stock transaction, with each Core Scientific share converted into 0.1235 shares of CoreWeave Class A common stock, subject to Core Scientific stockholder approval and customary closing conditions including regulatory approvals.
Source (primary)
core-scientific 8-K exhibit (q22025corescientificinc-ea.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-07)Live source ↗
Quote: “On July 7, 2025, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CoreWeave. Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein, CoreWeave will acquire the Company in an all-stock transaction... equal to the exchange ratio of 0.1235. The transaction is subject to the approval of the Company’s stockholders and customary closing conditions, including applicable regulatory approvals.”
How we checked this
Checked on October 9, 2026. The cited source supports every part of this claim.
The earnings release's 'Pending CoreWeave Transaction' section states the date, the all-stock structure, the 0.1235 exchange ratio into CoreWeave Class A shares, and the stockholder and regulatory approval conditions.
Confirmed in the source:
- Core Scientific entered into an Agreement and Plan of Merger with CoreWeave on July 7, 2025
- CoreWeave will acquire Core Scientific in an all-stock transaction
- Each outstanding Core Scientific share will be converted into CoreWeave Class A common stock at an exchange ratio of 0.1235
- The transaction is subject to Core Scientific stockholder approval
- The transaction is subject to customary closing conditions, including applicable regulatory approvals
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000162828025039283/q22025corescientificinc-ea.htm) in full (28,889 characters, retrieved October 7, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (q22025corescientificinc-ea.htm)
Quote: “On July 7, 2025, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CoreWeave. Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein, CoreWeave will acquire the Company in an all-stock transaction... equal to the exchange ratio of 0.1235. The transaction is subject to the approval of the Company’s stockholders and customary closing conditions, including applicable regulatory approvals.”